BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 18061249)

  • 1. Treatment options in stage I endometrial stromal sarcoma: a retrospective analysis of 53 cases.
    Li N; Wu LY; Zhang HT; An JS; Li XG; Ma SK
    Gynecol Oncol; 2008 Feb; 108(2):306-11. PubMed ID: 18061249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment and prognosis of low-grade malignant endometrial stromal sarcoma].
    Ma SK; Zhang HT; Wu LY; Liu LY; Li B
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):74-8. PubMed ID: 17575701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical review of 97 patients with endometrial stromal sarcoma].
    Li N; Wu LY; Zhang HT; An JS; Li XG; Ma SK
    Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):115-9. PubMed ID: 18683750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients.
    Bodner K; Bodner-Adler B; Obermair A; Windbichler G; Petru E; Mayerhofer S; Czerwenka K; Leodolter S; Kainz C; Mayerhofer K
    Gynecol Oncol; 2001 May; 81(2):160-5. PubMed ID: 11330943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression.
    Geller MA; Argenta P; Bradley W; Dusenbery KE; Brooker D; Downs LS; Judson PL; Carson LF; Boente MP
    Gynecol Oncol; 2004 Dec; 95(3):632-6. PubMed ID: 15581975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial stromal sarcomas--a retrospective analysis of 11 patients.
    Diesing D; Cordes T; Finas D; Löning M; Mayer K; Diedrich K; Friedrich M
    Anticancer Res; 2006; 26(1B):655-61. PubMed ID: 16739335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome and prognostic factors in endometrial stromal tumors: a Rare Cancer Network study.
    Schick U; Bolukbasi Y; Thariat J; Abdah-Bortnyak R; Kuten A; Igdem S; Caglar H; Ozsaran Z; Lössl K; Schleicher U; Zwahlen D; Villette S; Vees H
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):e757-63. PubMed ID: 22300565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
    Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
    Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgery and adjuvant radiation therapy of endometrial stromal sarcoma.
    Weitmann HD; Kucera H; Knocke TH; Pötter R
    Wien Klin Wochenschr; 2002 Jan; 114(1-2):44-9. PubMed ID: 12407935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study.
    Susumu N; Sagae S; Udagawa Y; Niwa K; Kuramoto H; Satoh S; Kudo R;
    Gynecol Oncol; 2008 Jan; 108(1):226-33. PubMed ID: 17996926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial stromal sarcoma: analysis of recurrence following adjuvant treatment.
    Beck TL; Singhal PK; Ehrenberg HM; Rose PG; Lele SB; Krivak TC; McBee WC
    Gynecol Oncol; 2012 Apr; 125(1):141-4. PubMed ID: 22119993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgically staged high-risk endometrial cancer: randomized study of adjuvant radiotherapy alone vs. sequential chemo-radiotherapy.
    Kuoppala T; Mäenpää J; Tomas E; Puistola U; Salmi T; Grenman S; Lehtovirta P; Fors M; Luukkaala T; Sipilä P
    Gynecol Oncol; 2008 Aug; 110(2):190-5. PubMed ID: 18534669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian preservation in stage I low-grade endometrial stromal sarcomas.
    Li AJ; Giuntoli RL; Drake R; Byun SY; Rojas F; Barbuto D; Klipfel N; Edmonds P; Miller DS; Karlan BY
    Obstet Gynecol; 2005 Dec; 106(6):1304-8. PubMed ID: 16319256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
    Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
    Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors and outcome in women with uterine sarcoma.
    Denschlag D; Masoud I; Stanimir G; Gilbert L
    Eur J Surg Oncol; 2007 Feb; 33(1):91-5. PubMed ID: 17174517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multi-institutional review of outcomes of endometrial stromal sarcoma.
    Leath CA; Huh WK; Hyde J; Cohn DE; Resnick KE; Taylor NP; Powell MA; Mutch DG; Bradley WH; Geller MA; Argenta PA; Gold MA
    Gynecol Oncol; 2007 Jun; 105(3):630-4. PubMed ID: 17320937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial stromal sarcoma: analysis of treatment failures and survival.
    Gadducci A; Sartori E; Landoni F; Zola P; Maggino T; Urgesi A; Lissoni A; Losa G; Fanucchi A
    Gynecol Oncol; 1996 Nov; 63(2):247-53. PubMed ID: 8910635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of stage IV "high-grade" endometrial stromal sarcoma with ifosfamide, adriamycin, and cisplatin.
    Yamawaki T; Shimizu Y; Hasumi K
    Gynecol Oncol; 1997 Feb; 64(2):265-9. PubMed ID: 9038274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes.
    Hoekstra AV; Kim RJ; Small W; Rademaker AW; Helenowski IB; Singh DK; Schink JC; Lurain JR
    Gynecol Oncol; 2009 Aug; 114(2):273-8. PubMed ID: 19428094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
    Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
    Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.